Timolol after myocardial infarction: an answer or a new set of questions?
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D000328:Adult; D000367:Age Factors; D000368:Aged; D002986:Clinical Trials as Topic / Q000379:methods; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000401:mortality / Q000517:prevention & control*; D011336:Probability; D011412:Propanolamines / Q000627:therapeutic use*; D011897:Random Allocation; D012107:Research Design; D013997:Time Factors; D013999:Timolol / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D013999:Timolol